HSP90 Expression Associated with HER2 Overexpressing Breast Ductal Carcinomas in African American Women

被引：0
|
作者：
Khan, Farhan [1 ]
Ricks-Santi, Luisel [2 ]
Hudson, Tamaro [1 ]
Beyene, Desta [1 ]
Naab, Tammey [1 ]
机构：
[1] Howard Univ Hosp, Washington, DC USA
[2] Hampton Univ, Hampton, VA 23668 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2016年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
297
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Insights into designing the dual-targeted HER2/HSP90 inhibitors
    Chen, Chien-Yu
    Chen, Calvin Yu-Chian
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2010, 29 (01): : 21 - 31
  • [22] HSP90 INHIBITORS POTENTIALLY OVERCOME CHEMORADIOTHERAPY RESISTANCE ASSOCIATED WITH HER2 AND NFfEB OVEREXPRESSION IN MIBC
    Yoshida, Soichiro
    Koga, Fumitaka
    Tatokoro, Manabu
    Kawakami, Satoru
    Fujii, Yasuhisa
    Kumagai, Jiro
    Neckers, Len
    Kihara, Kazunori
    JOURNAL OF UROLOGY, 2011, 185 (04): : E424 - E424
  • [23] Metformin inhibits proliferation and promotes apoptosis of HER2 positive breast cancer cells by downregulating HSP90
    Chen Tian-wen
    Liang Ya-nan
    Feng Duo
    Tao Lin-yu
    Qi Ke
    Zhang Hao-yun
    Wang Hong-xian
    Lin Qiu-sheng
    Kong Heng
    JOURNAL OF BUON, 2013, 18 (01): : 51 - 56
  • [24] High HSP90 expression is associated with decreased survival in breast cancer
    Pick, Elah
    Kluger, Yuval
    Giltnane, Jennifer M.
    Moeder, Christopher
    Camp, Robert L.
    Rimm, David L.
    Kluger, Harriet M.
    CANCER RESEARCH, 2007, 67 (07) : 2932 - 2937
  • [25] Phosphorylated HER2 expression is highly specific for HER2 gene amplification in female invasive ductal carcinomas
    Koseki, Masato
    Taniyama, Kiyomi
    Motoshita, Junichi
    Teramoto, Seiichi
    Tani, Yoichi
    CANCER RESEARCH, 2006, 66 (08)
  • [26] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Isabel Pinhel
    Margaret Hills
    Suzanne Drury
    Janine Salter
    Georges Sumo
    Roger A'Hern
    Judith M Bliss
    Ivana Sestak
    Jack Cuzick
    Peter Barrett-Lee
    Adrian Harris
    Mitch Dowsett
    Breast Cancer Research, 14
  • [27] ER and HER2 expression are positively correlated in HER2 non-overexpressing breast cancer
    Pinhel, Isabel
    Hills, Margaret
    Drury, Suzanne
    Salter, Janine
    Sumo, Georges
    A'Hern, Roger
    Bliss, Judith M.
    Sestak, Ivana
    Cuzick, Jack
    Barrett-Lee, Peter
    Harris, Adrian
    Dowsett, Mitch
    BREAST CANCER RESEARCH, 2012, 14 (02)
  • [28] HER2 and HSP90 overexpression in respect to KRAS gene status in colorectal cancer
    Bar, J.
    Lis-Nawara, A.
    Lebioda, A.
    Jonkisz, A.
    Grelewski, P.
    Gajdzis, P.
    Dobosz, T.
    Jelen, M.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 315 - 315
  • [29] Extracellular cleaved HER2 (p95) confers partial resistance to trastuzumab but not HSP90 inhibitors in models of HER2 amplified breast cancer
    Chandarlapaty, S.
    Scaltriti, M.
    Baselga, J.
    Ye, Q.
    Solit, D.
    Norton, L.
    Rosen, N.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [30] Blockade of Her2 binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2
    Fu, Liwu
    Zheng, Lisheng
    Yan, Yan-yan
    CANCER RESEARCH, 2011, 71
12345